Literature DB >> 19646188

Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population.

C S Arun1, A Al-Bermani, K Stannard, R Taylor.   

Abstract

AIMS: Diabetic retinopathy has long been regarded as the commonest preventable cause of blindness in the working age population. The aim was to determine if consistent annual screening for treatable retinopathy decreased the incidence of new blindness.
METHODS: We collated the causes of blindness for a 5-year period between 2001 and 2005 for the 16- to 64-year age group in a district that had operated systematic retinal screening in diabetes since 1986.
RESULTS: Diabetic retinopathy was found to be the second commonest cause of blindness, with optic atrophy being the commonest cause in Newcastle District. This differs from national data showing diabetic retinopathy to be the commonest cause. Diabetic retinopathy was also the second commonest cause of partial sightedness registrations, with stroke being the commonest cause. Overall, stroke disease accounted for 16.2% and diabetic retinopathy for 15.4% of registrations. The annual incidence of blindness was 0.22 per 1000 with diabetes and of partial sightedness 0.43 per 1000 with diabetes.
CONCLUSIONS: In a district that has operated retinal screening since 1986, diabetic retinopathy was not the commonest cause of blindness in the working age population, consistent with an effect of systematic annual screening.

Entities:  

Mesh:

Year:  2009        PMID: 19646188     DOI: 10.1111/j.1464-5491.2009.02718.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Assessment of automated disease detection in diabetic retinopathy screening using two-field photography.

Authors:  Keith Goatman; Amanda Charnley; Laura Webster; Stephen Nussey
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

2.  Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK).

Authors:  Sobha Sivaprasad; Bhaskar Gupta; Martin C Gulliford; Hiten Dodhia; Samantha Mann; Dinesh Nagi; Jennifer Evans
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

3.  Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.

Authors:  V Manjunath; V Papastavrou; D H W Steel; G Menon; R Taylor; T Peto; J Talks
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

4.  Grading diabetic retinopathy (DR) using the Scottish grading protocol.

Authors:  Sonia Zachariah; William Wykes; David Yorston
Journal:  Community Eye Health       Date:  2015

5.  The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application.

Authors:  Giuseppe Scarpa; Francesca Urban; Stela Vujosevic; Michele Tessarin; Giovanni Gallo; Annalisa Visentin; Emanuela Foglia; Lucrezia Ferrario; Edoardo Midena
Journal:  J Ophthalmol       Date:  2016-11-03       Impact factor: 1.909

6.  Expanding the role of medical retina virtual clinics using multimodal ultra-widefield and optical coherence tomography imaging.

Authors:  Jing Xian Lee; Vina Manjunath; S James Talks
Journal:  Clin Ophthalmol       Date:  2018-11-15

7.  The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.

Authors:  Peter H Scanlon
Journal:  Acta Diabetol       Date:  2021-04-08       Impact factor: 4.280

8.  SCREENING FOR DIABETIC RETINOPATHY - A TWELVE-MONTH REVIEW.

Authors:  Tomaž Gračner
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

9.  Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  Tamara J LeCaire; Mari Palta; Ronald Klein; Barbara E K Klein; Karen J Cruickshanks
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

10.  Risk factors for visual impairment and blindness amongst black adult diabetics receiving treatment at Government healthcare facilities in Mopani District, Limpopo province, South Africa.

Authors:  Raymond G Mabaso; Olalekan A Oduntan
Journal:  Afr J Prim Health Care Fam Med       Date:  2014-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.